Drug Polymorphism Analysis
Drug Polymorphism Analysis is a spectroscopic methodology that identifies and characterizes the distinct crystalline forms of a pharmaceutical compound to assess their impact on drug stability, solubility, and bioavailability.
240
Publications
10.1K
Citations
876
Authors
333
Institutions
Publications per year
2017–2026
37
240
HUMAN ACETYLATION POLYMORPHISM.
David A. Evans, Thomas A. White · PubMed · 1964 · 302 citations
Medicine, Pharmacology, Enzymology +12
Polymorphism in Carbamazepine Cocrystals
W. Porter, Sophia C. Elie, Adam J. Matzger · Crystal Growth & Design · 2008 · 265 citations · Full text
1–5 of 240
876
6
h-index
4
h-index
4
h-index
4
h-index
4
h-index
1–5 of 876
333

Universität Innsbruck
Innsbruck, Austria
12 h-index
29 publications
1.7K citations
Laboratoire de Chimie Physique
Orsay, France
7 h-index
19 publications
501 citations
University of Michigan
Ann Arbor, United States
6 h-index
15 publications
1.7K citations

University of Bologna
Bologna, Italy
5 h-index
11 publications
301 citations

University of Otago
Dunedin, New Zealand
5 h-index
23 publications
1.5K citations
University of Hyderabad
Hyderabad, India
5 h-index
12 publications
660 citations

Royal Hallamshire Hospital
Sheffield, United Kingdom
4 h-index
12 publications
489 citations

University of Ljubljana
Ljubljana, Slovenia
4 h-index
11 publications
497 citations
1–8 of 333
24 publications · 1.1K citations
19
h-index
18 publications · 673 citations
16
h-index
14 publications · 682 citations
14
h-index
JPP · 12 publications · 279 citations
11
h-index
10 publications · 600 citations
10
h-index
1–5